Stocktoria

PRF Technologies Ltd. PRFX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-09-01

PRF Technologies Ltd. statistics & valuation

Market cap$1.3M
P / S77.2×
P / B0.1×
Net margin-29541.2%
Return on equity-54.1%
FCF margin-23276.5%
Return on capital-53.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-29541.20% 2019202020212022202320242025
Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-30129.40% 2019202020212022202320242025
Return on equity (%)
-24.40% -40.10% -79.80% -129.10% -799.80% -54.10% 2019202020212022202320242025
Shares outstanding
576556 8.8M 10.5M 10.6M 1.7M 1.5M 830613 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-109.90% -22.80% -38.00% -71.30% -94.10% -322.40% -41.90% 2019202020212022202320242025
Free cash flow margin (%)
-23276.50% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$1.25 -$7.25 -$63.46 -$122.94 -$105.52 -$7.47 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-30129.4%——————
Net margin-29541.2%——————
FCF margin-23276.5%——————
Return on assets-41.9%-322.4%-94.1%-71.3%-38.0%-22.8%-109.9%
Return on equity-54.1%-799.8%-129.1%-79.8%-40.1%-24.4%10.4%
Current ratio1.781.814.0711.5525.1318.510.15

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.